Literature DB >> 21593155

Immune mediators of rotavirus antigenemia clearance in mice.

Glendie Marcelin1, Amber D Miller, Sarah E Blutt, Margaret E Conner.   

Abstract

The immunological mediators that clear rotavirus antigenemia or viremia remain undefined. Immunodeficient mice and antibody transfer were used to test whether lymphocytes or rotavirus-specific serum antibodies are essential for resolving antigenemia. Clearance of antigenemia required lymphocytes, but neither T nor B lymphocytes were absolutely required. Transfer of convalescent-phase or nonneutralizing rotavirus-specific serum antibodies to the systemic compartment of severe-combined-immunodeficient (SCID) mice temporarily suppressed the onset or level of chronic rotavirus antigenemia. Our findings provide the first report demonstrating that clearance of rotavirus antigenemia and possibly viremia are mediated by multiple effector lymphocyte subsets and serum antibodies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593155      PMCID: PMC3147920          DOI: 10.1128/JVI.00844-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.

Authors:  Andrea Bertolotti-Ciarlet; Max Ciarlet; Sue E Crawford; Margaret E Conner; Mary K Estes
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

Review 2.  Pathogenesis of intestinal and systemic rotavirus infection.

Authors:  Robert F Ramig
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.

Authors:  Blaise Corthésy; Yann Benureau; Clémentine Perrier; Cynthia Fourgeux; Nathalie Parez; Harry Greenberg; Isabelle Schwartz-Cornil
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 4.  Immunity to rotavirus infection in mice.

Authors:  M A Franco; H B Greenberg
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs).

Authors:  Sarah E Blutt; Kelly L Warfield; Christine M O'Neal; Mary K Estes; Margaret E Conner
Journal:  Vaccine       Date:  2005-09-09       Impact factor: 3.641

6.  Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus.

Authors:  M S Azevedo; L Yuan; K-I Jeong; A Gonzalez; T V Nguyen; S Pouly; M Gochnauer; W Zhang; A Azevedo; L J Saif
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Functional T cells in athymic nude mice.

Authors:  S Ikehara; R N Pahwa; G Fernandes; C T Hansen; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

Authors:  J W Burns; M Siadat-Pajouh; A A Krishnaney; H B Greenberg
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

Review 9.  Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS.

Authors:  Shuji Sato; Welkin Johnson
Journal:  Curr HIV Res       Date:  2007-11       Impact factor: 1.581

10.  Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.

Authors:  Lars Hangartner; Raphaël M Zellweger; Mattia Giobbi; Jacqueline Weber; Bruno Eschli; Kathy D McCoy; Nicola Harris; Mike Recher; Rolf M Zinkernagel; Hans Hengartner
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

View more
  7 in total

1.  Human rotavirus-specific IgM Memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivo.

Authors:  Carlos F Narváez; Ningguo Feng; Camilo Vásquez; Adrish Sen; Juana Angel; Harry B Greenberg; Manuel A Franco
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

2.  FoxP3+ regulatory T cells are not important for rotavirus clearance or the early antibody response to rotavirus.

Authors:  Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  Microbes Infect       Date:  2013-10-02       Impact factor: 2.700

3.  Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses.

Authors:  Emily M Deal; Katharina Lahl; Carlos F Narváez; Eugene C Butcher; Harry B Greenberg
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

Review 4.  Rotavirus and biliary atresia: can causation be proven?

Authors:  Paula M Hertel; Mary K Estes
Journal:  Curr Opin Gastroenterol       Date:  2012-01       Impact factor: 3.287

5.  IgA is important for clearance and critical for protection from rotavirus infection.

Authors:  S E Blutt; A D Miller; S L Salmon; D W Metzger; M E Conner
Journal:  Mucosal Immunol       Date:  2012-06-27       Impact factor: 7.313

6.  A CD22-Shp1 phosphatase axis controls integrin β7 display and B cell function in mucosal immunity.

Authors:  Martin Brennan; Carolin Brandl; Romain Ballet; Ningguo Feng; Jeremy Berri; Julian Cheng; Borja Ocón; Amin Alborzian Deh Sheikh; Alex Marki; Yuhan Bi; Clare L Abram; Clifford A Lowell; Takeshi Tsubata; Harry B Greenberg; Matthew S Macauley; Klaus Ley; Lars Nitschke; Eugene C Butcher
Journal:  Nat Immunol       Date:  2021-02-15       Impact factor: 25.606

Review 7.  The gastrointestinal frontier: IgA and viruses.

Authors:  Sarah E Blutt; Margaret E Conner
Journal:  Front Immunol       Date:  2013-11-28       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.